RT Book, Section
A1 Hariharan, Luxme
A1 Starr, Ellery Lopez
A1 Garcia, Renata
A1 Penniecook, Jason A.
A1 Pettey, Jeff
A1 Hanson, Eric
A1 Morjaria, Priya
A1 Noah, Josie
A1 Haddad, Danny
A1 Mezu-Ndubuisi, Olachi J.
A1 Winthrop, Kevin L.
A1 Ventura, Camila V.
A1 Lansingh, Van Charles
A2 Boulton, Matthew L.
A2 Wallace, Robert B.
SR Print(0)
ID 1182672244
T1 Visual Disorders
T2 Maxcy-Rosenau-Last Public Health & Preventive Medicine, 16e
YR 2022
FD 2022
PB McGraw Hill
PP New York, NY
SN 9781259644511
LK accessmedicine.mhmedical.com/content.aspx?aid=1182672244
RD 2024/04/19
AB Visual  disorders  such  as  uncorrected  refractive  error  (URE),  cataract,  glaucoma,  diabetic  retinopathy,  and  retinopathy  of  prematurity  (ROP)  are  leading  public  health  problems  worldwide,  causing  significant  morbidity  and  dramatically  affecting  the  lives  of  hundreds  of  millions  of  people  daily.  Overall,  75–80%  of  the  causes  of  blindness  and  visual  impairment  (VI)  are  avoidable  or  treatable  with  early  detection,  evidence-based  screening,  and  timely  treatment.  More  specifically,  for  2015,  it  was  estimated  that  81.2%  of  the  blindness  is  preventable  or  treatable.1  Unfortunately,  90%  of  avoidable  blindness  disproportionately  affects  the  most  vulnerable  communities  including  the  poor,  women,  children,  the  elderly,  and  people  living  in  rural  areas.1,2